REARRANGEMENTS IN THE P53 GENE IN PHILADELPHIA-CHROMOSOME POSITIVE CHRONIC MYELOGENOUS LEUKEMIA
- 15 November 1989
- journal article
- research article
- Vol. 74 (7) , 2318-2324
Abstract
Molecular structural analysis of the p53 gene in patients with Philadelphia chromosome-positive chronic myelogenous leukemia (CML) indicates a significant incidence of gene rearrangements in patients at either accelerated phase or blastic crisis. Southern blot analysis of genomic DNA hybridizing with either genomic or cDNA p53 specific probes indicated that 30% of the CML patients at blastic crisis phase exhibited rearrangements, mostly mapping downstream to the first non-coding exon. This is compatible with the observation that the progression of CML from the chronic to the acute phase involves frequent aberrations in chromsomes 17, to which the p53 oncogene has been mapped. Therefore, we suggest that one of the pathways of development of CML to the acute phase is associated with aberrations in the p53 nuclear oncogene.This publication has 8 references indexed in Scilit:
- In vitro expression of human p53 cDNA clones and characterization of the cloned human p53 gene.Molecular and Cellular Biology, 1985
- Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells.Proceedings of the National Academy of Sciences, 1985
- Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 geneCell, 1984
- An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activityCell, 1984
- Molecular cloning of a cDNA specific for the murine p53 cellular tumor antigen.Proceedings of the National Academy of Sciences, 1983
- Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny.Molecular and Cellular Biology, 1982
- p53 transformation-related protein: Detection by monoclonal antibody in mouse and human cellsProceedings of the National Academy of Sciences, 1981
- Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.Proceedings of the National Academy of Sciences, 1979